Harvard Apparatus Regenerative Technology Announces Strategic Collaboration with Children’s Hospital Capital institute of Pediatrics in Beijing, China to Advance Treatment for Esophageal Atresia
Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
Harvard Apparatus Appoints Mao Zhang to Board of Directors
Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
